Cargando…

Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma

PURPOSE: In the current study, we aimed to evaluate the neutralizing IgG activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as the coagulation factors of convalescent plasmas which we manufactured in-house without a fast-freezing technique. METHODS: We collected pl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inada, Makoto, Togano, Tomiteru, Terada, Mari, Shiratori, Katsuyuki, Tsuzuki, Shinya, Takamatsu, Yuki, Saito, Sho, Hangaishi, Akira, Morioka, Shinichiro, Kutsuna, Satoshi, Maeda, Kenji, Mitsuya, Hiroaki, Ohmagari, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797217/ https://www.ncbi.nlm.nih.gov/pubmed/36610860 http://dx.doi.org/10.1016/j.transci.2022.103638

Ejemplares similares

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)
por: Tomita, Noriko, et al.
Publicado: (2022)

Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals
por: Terada, Mari, et al.
Publicado: (2023)

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial
por: Saito, Sho, et al.
Publicado: (2023)

The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan
por: Kamo-Imai, Ayumi, et al.
Publicado: (2023)

Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan
por: Suzuki, Tetsuya, et al.
Publicado: (2022)

Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants
por: Tsuchiya, Kiyoto, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
por: Maeda, Kenji, et al.
Publicado: (2021)

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
por: Miyazato, Yusuke, et al.
Publicado: (2020)

SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response
por: Takamatsu, Yuki, et al.
Publicado: (2022)

SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response
por: Takamatsu, Yuki, et al.
Publicado: (2022)

Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection
por: Inada, Makoto, et al.
Publicado: (2022)

We Should Pay More Attention to Sex Differences to Predict the Risk of Severe COVID-19: Men Have the Same Risk of Worse Prognosis as Women More Than 10 Years Older
por: Matsushita, Yumi, et al.
Publicado: (2023)

Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
por: Kutsuna, Satoshi, et al.
Publicado: (2021)

The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan
por: Togano, Tomiteru, et al.
Publicado: (2021)

Considerations and concerns regarding the readiness to remove face coverings
por: Terada, Mari, et al.
Publicado: (2022)

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
por: Miyazato, Yusuke, et al.
Publicado: (2022)

No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity
por: Nomoto, Hidetoshi, et al.
Publicado: (2021)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
por: Terada, Mari, et al.
Publicado: (2021)

Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: A modelling study
por: Asai, Yusuke, et al.
Publicado: (2021)

A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy
por: Kamegai, Kohei, et al.
Publicado: (2022)

Beau's Lines and Leukonychia in a COVID-19 Patient
por: Ide, Satoshi, et al.
Publicado: (2020)

Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2022)

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics
por: Saito, Sho, et al.
Publicado: (2021)

Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study
por: Morioka, Shinichiro, et al.
Publicado: (2020)

Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection()
por: Suzuki, Tetsuya, et al.
Publicado: (2020)

Treatment with tecovirimat of the first two cases of monkeypox in Japan
por: Inada, Makoto, et al.
Publicado: (2023)

Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19
por: Miyazato, Yusuke, et al.
Publicado: (2022)

480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients
por: KAMEGAI, K O H E I, et al.
Publicado: (2023)

Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies
por: Inada, Makoto, et al.
Publicado: (2021)

Effect of temperature on the infectivity of COVID-19
por: Ujiie, Mugen, et al.
Publicado: (2020)

201. Characteristics of Streptococcal Toxic Shock Syndrome Caused by Different Beta-Hemolytic Streptococci Species: A Single-Center Retrospective Study
por: Inada, Makoto, et al.
Publicado: (2023)

Factors Associated With Prolonged Psychological Distress Among Nurses and Physicians Engaged in COVID-19 Patient Care in Singapore and Japan
por: Morioka, Shinichiro, et al.
Publicado: (2022)

Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012–2013 and 2018–2019
por: Nomoto, Hidetoshi, et al.
Publicado: (2020)

Correction: Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012–2013 and 2018–2019
por: Nomoto, Hidetoshi, et al.
Publicado: (2022)

Residual and Late Onset Symptoms Appeared in a Patient with Severe Fever with Thrombocytopenia in a Convalescence Stage
por: Kanda, Kohei, et al.
Publicado: (2021)

Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan
por: Okumura, Nobumasa, et al.
Publicado: (2022)

Scrub Typhus with Respiratory Symptoms
por: Taguchi, Maho, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pmrprcu5qlk0tc4fch61cl5ur9